Monday, 26 June 2017

Biologics News

  • Merck, Samsung to co-develop diabetes drug

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014

    Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, have expanded their collaboration  to develop, manufacture ...Read more

  • H7N9 antibodies high among poultry workers'

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014

    Singapore: Serological tests conducted on poultry workers of southern Guangdong province city of Shenzhen China, showed evidence of asymptomatic or mild infections in poultry workers, furth...Read more

  • Quintiles to advise Ascendancy on pharma deals in China

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013

    Singapore: San Francisco-based Ascendancy Healthcare has tied up with Quintiles to get help from the contract research giant in order to leverage on China's growing pharma market. Quintile...Read more

  • Scientists trace origin of skin-deep immune cells

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012

    Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful g...Read more

  • India's Polyclone collaborate with Greifswald Uni to engineer enzyme

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2014

    Singapore: India based Polyclone, a biotech company with expertise in molecular, cell and computational biology has collaborated with the Dept. of Biotechnology & Enzyme Catalysis of th...Read more

  • GE launches modular pharma factory

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012

    Singapore: GE Healthcare introduced KUBio, an innovative off-the-shelf, modular factory, designed to save manufacturers of biopharmaceuticals both time and money. KUBio's pre-made modules,...Read more

  • Green Cross builds $68 mn Thai plasma plant

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 13 Feb, 2013

    Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thailand. Green Cross, which signed the contract for the plant with the Th...Read more

  • Novozymes sales increased 7% in 2012

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2013

    Singapore: Novozymes reported seven percent sales growth in 2012 when compared with 2011. EBIT increased by 17 percent, raising the EBIT margin to 24.4 percent. Net profit grew by 10 percen...Read more

  • Biologics: Indian companies address quality issues

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    In recent years, licensing and quality control for manufacturers and national regulatory authorities has become more complex. The National Institute of Biologicals (NIB) has been working si...Read more

  • 3SBio, Selecta join hands to develop gout therapy

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014

    Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis. Pegsiti...Read more

  • GE launches single-use bioreactor system

    Biologics |  News | By BioSpectrum Bureau | 1 Comment | 19 Nov, 2013

    Singapore: GE Healthcare Life Sciences has launched ReadyToProcess Wave 25, a next-generation, single-use, rocking bioreactor system. The bioreactor system is an intuitive and easy-to-use c...Read more

  • TaiMed Biologics taps on humanized mAb for HIV therapy

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2012

    Publicly-held biotech company TaiMed Biologics was set up in 2007 with the mission to discover, develop and deliver innovative medicines that help patients prevail over serious infectious d...Read more

  • Aussie firm begins prostate cancer screening test in US

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2014

    Singapore: Australian biotechnology company Minomic is all set to launch two overseas trials of its MiStat prostate cancer screening test, following an agreement with the prestigious CUSP G...Read more

  • Cell death pioneer wins Agilent thought leader award

    Biologics |  Influencers | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2013

    Singapore: Dr Junying Yuan, a pioneer and leading researcher in the field of cell death at the Chinese Academy of Sciences, has received an Agilent Thought Leader award in recognition of he...Read more

  • Samsung to make Roche biologics at Korean plant

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Oct, 2013

    Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines...Read more

  • Sanofi begins biopharmaceutical plant construction

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014

    Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to the production of viral vectors, such as Transgene's MUC1 targeted c...Read more

  • Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014

    ‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0214, an investigational etanercept biosimilar for rheumatoid arthriti...Read more

  • Biologics' demand will boost cell culture, stem cell market

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2012

    Singapore: Cell culture is going to become the next big pharmaceutical trend, as laboratories rush to meet demand for stem cell and biologics, states a new report by healthcare experts GBI ...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls